Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin vs Glybenclamide for Gestational Diabetes
NCT01563120Phase 4Completed
- Sponsor
- Emek Medical Center
- Start
- Jan 2012
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of metformin, glibenclamide in gestational diabetes mellitus (GDM), sponsored by Emek Medical Center. Started Jan 2012; status: completed.
02
Drugs
metforminglibenclamide
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on NCT01563120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01563120.